Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$3.92B |
| 2 |
Visa
V
|
+$551M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$406M |
| 4 |
UnitedHealth
UNH
|
+$395M |
| 5 |
Advanced Micro Devices
AMD
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.41B |
| 2 |
NVIDIA
NVDA
|
+$2.28B |
| 3 |
Microsoft
MSFT
|
+$2.02B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.83B |
| 5 |
Flutter Entertainment
FLUT
|
+$962M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Consumer Discretionary | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 4.81% |
| 5 | Communication Services | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
RCI Hospitality Holdings
RICK
$192M
| $744K | ﹤0.01% |
12,944
-649
| -5% | -$31.7K |
|
3502
Camtek
CAMT
$6.52B
| $741K | ﹤0.01% |
9,177
+2,694
| +42% | +$212K |
|
3503
Red Violet
RDVT
$968M
| $741K | ﹤0.01% |
20,463
+1,961
| +11% | +$65.3K |
|
3504
UroGen Pharma
URGN
$1.88B
| $738K | ﹤0.01% |
69,325
+9,547
| +16% | +$114K |
|
|
TECX
3505
Tectonic Therapeutic
TECX
$527M
| $738K | ﹤0.01% |
15,974
+14,533
| +1,009% | +$615K |
|
3506
DoubleVerify
DV
$1.8B
| $737K | ﹤0.01% |
38,352
-17,096
| -31% | -$322K |
|
3507
Kodiak Sciences
KOD
$2.49B
| $736K | ﹤0.01% |
73,927
-5,731
| -7% | -$32.9K |
|
3508
JFrog
FROG
$9.98B
| $734K | ﹤0.01% |
24,956
+3,906
| +19% | +$119K |
|
3509
Titan International
TWI
$466M
| $733K | ﹤0.01% |
107,880
+211
| +0.2% | +$1.52K |
|
3510
Porch Group
PRCH
$1.82B
| $732K | ﹤0.01% |
148,715
+13,796
| +10% | +$44.3K |
|
3511
Eton Pharmaceutcials
ETON
$1.24B
| $731K | ﹤0.01% |
+54,886
| New | +$557K |
|
3512
Savara
SVRA
$1.09B
| $727K | ﹤0.01% |
236,705
+5,700
| +2% | +$19.9K |
|
3513
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $724K | ﹤0.01% |
17,734
+1,562
| +10% | +$65.7K |
|
3514
Grupo Aeroportuario del Sureste
ASR
$8.36B
| $721K | ﹤0.01% |
+2,797
| New | +$750K |
|
3515
Viant Technology
DSP
$245M
| $720K | ﹤0.01% |
37,935
-1,320
| -3% | -$20.6K |
|
3516
Nano X Imaging
NNOX
$76.6M
| $719K | ﹤0.01% |
99,929
+13,748
| +16% | +$88K |
|
3517
BigBear.ai
BBAI
$1.37B
| $718K | ﹤0.01% |
161,457
+19,691
| +14% | +$44.5K |
|
|
HAIAW
3518
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
| $718K | ﹤0.01% |
62,809
| – | – |
|
3519
Peoples Financial Services
PFIS
$704M
| $718K | ﹤0.01% |
14,023
+1,753
| +14% | +$89.1K |
|
|
ONTF
3520
DELISTED
ON24
ONTF
| $716K | ﹤0.01% |
110,804
+8,967
| +9% | +$57.6K |
|
3521
Akebia Therapeutics
AKBA
$351M
| $713K | ﹤0.01% |
375,495
+102,410
| +38% | +$178K |
|
3522
Sigma Lithium
SGML
$1.17B
| $712K | ﹤0.01% |
63,501
-4,391
| -6% | -$57.4K |
|
|
EVBN
3523
DELISTED
Evans Bancorp Inc
EVBN
| $712K | ﹤0.01% |
16,438
+275
| +2% | +$11.6K |
|
|
NLOP
3524
Net Lease Office Properties
NLOP
$178M
| $711K | ﹤0.01% |
22,780
+2,853
| +14% | +$88.7K |
|
3525
Xenon Pharmaceuticals
XENE
$6.02B
| $711K | ﹤0.01% |
18,127
+3,134
| +21% | +$130K |
|
Similar funds
Barclays's Q4 2024 Portfolio in Review
As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.
- Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
- Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
- Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
- Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
- Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
- Barclays opened 343 new positions and closed 348 in Q4 2024.
- Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.
Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.